With an excellent record of investing in quality growth companies, the fund bets big on the continent’s return to form ...

Most important is anti-blood-clot medicine Eliquis, which is due to lose patent exclusivity in 2026. Eliquis emerged last year as Pfizer’s top-performing drug, having grown rapidly to bring in $7.4bn ...

The Federal Reserve, by contrast, has left rates unchanged since last December, refusing to lower them in a succession of meetings. But this week’s steady US inflation data may now be the trigger to ...

Copper miner Antofagasta (ANTO) revved up its interim profits through higher gold and copper production, resulting in a mid-year payout twice that of last year. The cash profit was $2.2bn (£1.6bn), ...

The pound hit a month high after better-than-expected GDP figures, Wall Street keeps hitting record eyes and all eyes are on US President Donald Trump’s meeting with his Russian counterpart tomorrow.

Even so, small caps aren’t the only way of generating top returns. The best-performing Japanese fund over five years, Nomura Japan Strategic Value (IE00B3W35Q81), has a large-cap focus, while some ...